Not Signed In -
Heroin |
|
|
Clinical Trial: Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment III) - 3
This study has been completed.
Purpose
The purpose of this study is to compare the clinical efficacy of the buprenorphine/naloxone combination tablet to methadone for opioid maintenance treatment.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Heroin Dependence Opioid-Related Disorders | Drug: Opioid-Related Disorders | Phase II |
MedlinePlus related topics: Drug Abuse; Heroin Abuse
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment
Official Title: Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment III
Study start: July 1997
S/A brief "Summary for the Public"
Eligibility
Ages Eligible for Study: 18 Years - 65 Years, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
Individuals must be at least 18 years of age, currently opioid dependent and meet FDA critera for narcotic maintenance treatment. Co-morbid substance abuse or dependence disorders may also be present. Individuals must be healthy despite drug dependency.
Exclusion Criteria:
Individuals with evidence of an active DSM-IV Axis I psychiatric disorder (e.g. psychosis, manic-depressive illness, organic psychiatric disorders), significant medical illness (e.g. liver or cardiovascular disease) or pregnant female subjects are excluded from study participation.
Location Information
Colorado
University of Colorado Health Sciences Center, Denver, Colorado, 80206, United States
Leslie Amass, Ph.D., Principal Investigator, University of Colorado
More Information
Record last reviewed: July 1997
Last Updated: February 16, 2005
Record first received: September 20, 1999
ClinicalTrials.gov Identifier: NCT00000328
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 8, 2005
Resources
- Heroin (Cleveland Clinic)
- Heroin: Abuse and Addiction (Cleveland Clinic)
email this page
print this page
bookmark this page
feedback on this page
